SCHEMBL5486452

SCHEMBL5486452

CCC(Oc1ccc(Nc2ncnc3cccc(OCCN(C)C(C)=O)c23)cc1Cl)c1ccccn1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 20/20 0.63
EGFR P00533 9/20 0.63
KCNH2 Q12809 6/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5699162 0.85 ERBB2 (0.70) ERBB2EGFRKCNH2
SCHEMBL4481487 0.85 ERBB2 (0.85) ERBB2EGFRKCNH2
SCHEMBL4479915 0.82 ERBB2 (0.65) ERBB2EGFRKCNH2
SCHEMBL4485031 0.81 ERBB2 (0.62) ERBB2EGFRKCNH2
SCHEMBL4481271 0.80 ERBB2 (0.65) ERBB2EGFRKCNH2
SCHEMBL4474648 0.80 ERBB2 (0.87) ERBB2EGFRKCNH2
SCHEMBL4469132 0.79 ERBB2 (0.71) ERBB2EGFRKCNH2
SCHEMBL4473766 0.79 ERBB2 (0.75) ERBB2EGFRKCNH2
SCHEMBL4476676 0.79 ERBB2 (0.77) ERBB2EGFRKCNH2
SCHEMBL4466446 0.78 ERBB2 (0.70) ERBB2EGFRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007511491-A 2007-05-10 JP claimed
EP-1685116-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-08-02 EP claimed
WO-2005051923-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-06-09 WO claimed
EP-1685116-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-08-02 EP disclosed
WO-2005051923-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-06-09 WO disclosed